19940605
 Mallinckrodt Group Inc.: Scanner for tumors receives FDA marketing approval   The Wall Street Journal,  Jun 6, 1994  The FDA has granted marketing approval to Mallinckrodt Group Inc's OctreoScan radiopharmaceutical, an imaging agent designed to allow physicians to made definitive diagnoses of certain cancer tumors using a noninvasive procedure.   
